Effect of metformin on the clinical and metabolic assessment of women with polycystic ovary syndrome.

Abstract

A longitudinal prospective study was conducted in 21 women with polycistic ovary syndrome (PCOS), aged 27.20 +/- 5.02 years and treated with metformin (1500 mg/day)for 8 weeks. The patients were assessed for spontaneous menstruation, weight, body mass index (BMI), waist circumference, waist/hip ratio (WHR), glucose and insulin concentrations under fasting… (More)

Topics

Cite this paper

@article{Santana2004EffectOM, title={Effect of metformin on the clinical and metabolic assessment of women with polycystic ovary syndrome.}, author={L Ferreira Santana and Marcos Felipe Silva de S{\'a} and Rui Alberto Ferriani and Marcos Dias de Moura and Milton C{\'e}sar Foss and Rosana Maria Dos Reis}, journal={Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology}, year={2004}, volume={19 2}, pages={88-96} }